Committee for Medicinal Products for Human Use
E139009
The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
All labels observed (4)
| Label | Occurrences |
|---|---|
| Committee for Medicinal Products for Human Use canonical | 14 |
| CHMP | 3 |
| Committee for Medicinal Products for Human Use within the European Medicines Agency | 1 |
| European Medicines Agency | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T1143214 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Committee for Medicinal Products for Human Use Context triple: [European Medicines Agency, hasCommittee, Committee for Medicinal Products for Human Use]
-
A.
Committee for Herbal Medicinal Products
The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
D.
Committee for Orphan Medicinal Products
The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
-
E.
Committee for Medicinal Products for Veterinary Use
The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Committee for Medicinal Products for Human Use Target entity description: The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
-
A.
Committee for Herbal Medicinal Products
The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
D.
Committee for Orphan Medicinal Products
The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
-
E.
Committee for Medicinal Products for Veterinary Use
The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
- F. None of above. chosen
Statements (50)
| Predicate | Object |
|---|---|
| instanceOf |
expert body
ⓘ
regulatory body ⓘ scientific committee ⓘ |
| abbreviation |
Committee for Medicinal Products for Human Use
self-linksurface differs
ⓘ
surface form:
CHMP
|
| appliesTo |
advanced therapy medicinal products
ⓘ
biosimilar medicines ⓘ centrally authorised medicines ⓘ generic medicines ⓘ innovative medicines ⓘ orphan medicines ⓘ |
| composition |
co-opted members with specific expertise
ⓘ
members nominated by EEA-EFTA states ⓘ members nominated by EU Member States ⓘ |
| country | European Union ⓘ |
| domain | medicinal products for human use ⓘ |
| field |
biostatistics
ⓘ
clinical pharmacology ⓘ drug safety ⓘ medicine regulation ⓘ pharmaceutical quality ⓘ pharmacology ⓘ public health ⓘ toxicology ⓘ |
| formerlyKnownAs | Committee for Proprietary Medicinal Products ⓘ |
| hasRole |
adopt opinions on referrals for medicines
ⓘ
advise European Commission on medicinal products ⓘ assess efficacy of medicines ⓘ assess quality of medicines ⓘ assess safety of medicines ⓘ contribute to development of EU guidelines on medicinal products ⓘ coordinate EU-wide assessment of medicines ⓘ evaluate medicinal products for human use ⓘ issue opinions on benefit–risk balance of medicines ⓘ prepare opinions on extensions of marketing authorisations ⓘ prepare opinions on marketing authorisation applications ⓘ prepare opinions on renewals of marketing authorisations ⓘ prepare opinions on variations to marketing authorisations ⓘ provide scientific advice to medicine developers ⓘ provide scientific opinions on medicines ⓘ support pharmacovigilance activities ⓘ |
| headquartersLocation |
Amsterdam
ⓘ
Netherlands ⓘ |
| jurisdiction | European Union ⓘ |
| language | English ⓘ |
| parentOrganization | European Medicines Agency ⓘ |
| partOf | European Medicines Agency ⓘ |
| replaced | Committee for Proprietary Medicinal Products ⓘ |
| worksWith |
Committee for Advanced Therapies
ⓘ
Committee for Orphan Medicinal Products ⓘ Pharmacovigilance Risk Assessment Committee ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Committee for Medicinal Products for Human Use Description of subject: The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
Referenced by (19)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject surface form:
European Medicines Agency
this entity surface form:
Committee for Medicinal Products for Human Use within the European Medicines Agency
Committee for Proprietary Medicinal Products
→
replacedBy
→
Committee for Medicinal Products for Human Use
ⓘ
Committee for Proprietary Medicinal Products
→
hasSuccessor
→
Committee for Medicinal Products for Human Use
ⓘ
Committee for Proprietary Medicinal Products
→
reorganizedInto
→
Committee for Medicinal Products for Human Use
ⓘ
Pharmacovigilance Risk Assessment Committee
→
collaboratesWith
→
Committee for Medicinal Products for Human Use
ⓘ
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
→
worksWith
→
Committee for Medicinal Products for Human Use
ⓘ
subject surface form:
Pharmacovigilance Risk Assessment Committee
this entity surface form:
European Medicines Agency
this entity surface form:
CHMP
Coordination Group for Mutual Recognition and Decentralised Procedures – Human
→
collaboratesWith
→
Committee for Medicinal Products for Human Use
ⓘ
subject surface form:
Committee for Advanced Therapies
Committee for Medicinal Products for Human Use
→
abbreviation
→
Committee for Medicinal Products for Human Use
self-linksurface differs
ⓘ
this entity surface form:
CHMP